As of 2026-04-17, the Relative Valuation of Bright Minds Biosciences Inc (DRUG.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 123.00 CAD, the upside of Bright Minds Biosciences Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2026-04-10 | -57.06 |
| 2026-04-09 | -58.65 |
| 2026-04-08 | -56.24 |
| 2026-04-07 | -52.63 |
| 2026-04-06 | -51.37 |
| 2026-04-02 | -48.33 |
| 2026-04-01 | -48.38 |
| 2026-03-31 | -50.01 |
| 2026-03-30 | -47.07 |
| 2026-03-27 | -47.91 |
| 2026-03-26 | -49.99 |
| 2026-03-25 | -49.77 |
| 2026-03-24 | -48.81 |
| 2026-03-23 | -49.96 |
| 2026-03-20 | -49.35 |
| 2026-03-19 | -49.41 |
| 2026-03-18 | -47.68 |
| 2026-03-16 | -50.94 |
| 2026-03-13 | -49.87 |
| 2026-03-12 | -48.26 |
| 2026-03-11 | -50.32 |
| 2026-03-10 | -55.42 |
| 2026-03-09 | -54.24 |
| 2026-03-06 | -50.67 |
| 2026-03-05 | -52.70 |
| 2026-03-04 | -53.40 |
| 2026-03-03 | -53.60 |
| 2026-02-27 | -54.78 |
| 2026-02-26 | -58.31 |
| 2026-02-25 | -60.77 |
| 2026-02-24 | -59.22 |
| 2026-02-23 | -56.96 |
| 2026-02-20 | -58.22 |
| 2026-02-19 | -56.78 |
| 2026-02-18 | -55.01 |
| 2026-02-17 | -56.61 |
| 2026-02-13 | -51.06 |
| 2026-02-12 | -53.61 |
| 2026-02-11 | -52.03 |
| 2026-02-09 | -50.96 |
| 2026-02-06 | -51.46 |
| 2026-02-05 | -52.39 |
| 2026-02-04 | -50.96 |
| 2026-02-03 | -52.51 |
| 2026-02-02 | -54.54 |
| 2026-01-30 | -53.02 |
| 2026-01-29 | -55.19 |
| 2026-01-28 | -54.42 |
| 2026-01-27 | -57.22 |
| 2026-01-26 | -57.71 |